An in vitro study using MCF-7 breast cancer cells demonstrated that curcumin dose-dependently impedes the metastatic progression via suppression of urinary-type plasminogen activator (uPA) by downregulating NF-κB signaling pathways [124]. The gene discussed is NFKB1; the disease is breast carcinoma.